Showing 681 - 700 results of 100,190 for search '(( 5 cm decrease ) OR ( 5 ((((step decrease) OR (we decrease))) OR (a decrease)) ))', query time: 1.58s Refine Results
  1. 681
  2. 682
  3. 683

    PSG-specific <i>Fzr</i> mutation decreases the expression of silk protein genes. by Wenliang Qian (639395)

    Published 2023
    “…For the significance test: *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.001 versus the control. Scale bar, 1cm. WT, wild type. L5D3, the third day of the fifth larval instar; L5D5, the fifth day of the fifth larval instar; W0, just wandering.…”
  4. 684

    Jurkat and HeLa survival decreases with increasing electric field amplitude and pulse number. by Bennett L. Ibey (357053)

    Published 2013
    “…<p>Cell survival curves for Jurkat and HeLa cells exposed to 60, 105, 150, and 285 kV/cm. The data shows that the number of cells that survive post-exposure decreases with increasing electric field and pulse number. …”
  5. 685
  6. 686

    Anti-EBOV GP IgGs Lacking α1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs by Olivier Reynard (354756)

    Published 2016
    “…In this paper, we explored whether low immunogenicity IgGs had a protective effect on a guinea pig model of Ebola virus (EBOV) infection. …”
  7. 687
  8. 688
  9. 689
  10. 690

    A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity by Regina Michelis (2889092)

    Published 2019
    “…In patients with abnormal C5, basal levels of sC5b-9 and C5a were increased while activities of the CP and of the CP C5-convertase, the immediate C5-upstream complex, were decreased compared to NC and to patients with normal C5. …”
  11. 691
  12. 692
  13. 693
  14. 694

    Enalaprilat and losartan decrease erythroid precursors frequency in cells from patients with polycythemia vera by Angela Bozza (8908091)

    Published 2023
    “…After the discovery of a mutation in the Janus kinase 2 (<i>JAK</i>2<sup>V617F</sup>), JAK2 inhibitors have been tested as second-line therapies. …”
  15. 695
  16. 696
  17. 697
  18. 698
  19. 699
  20. 700